Murli Krishna Pharma Pvt. Ltd.Innovative Solutions for Oral Dosage

Forms…..

Factory :

D-98, Ranjangaon, M.I.D.C., Ranjangaon, Taluka-Shirur, District – Pune, 412209 – Maharashtra.TEL.:00-91-2138 660771,660772. Fax: 00-91-2138232530.

Cop. Office:

No. 8, Pearl Bldg., Powai Vihar Complex, A.S.Marg, Powai, Mumbai – 400 076. India.Tel. : 00-91-22-25708138/3598/Fax : 00-91-22-25702054.Email: mkepl@vsnl.com Web Site: www.mkppl.com

……….we turn ideas into technology

Company Profile

• MKPPL is a Research based company manufacturing high value drug products in the form of Enteric Coated Pellets.

• European GMP certified plant for Omeprazole pellets

• 100% Export Oriented Unit (EOU)

• Single stop for Coating Solutions

• Commercial Production started in October 2005

• Compliance with regulatory standards – Both Indian and International

Vision

• Turning Technology dreams into reality.

Mission• Become a Global Pharmaceutical export company

• Continuing the development of Aqueous based Coating Techniques .

• Extending our expertise in designing Solid Dosage forms for Stents moving from the current Micro Encapsulation to Nano Encapsulation Using Aqueous Dispersion Techniques.

• Focusing on New and Novel Drug Deliveries with an eye on Patents

Our Strengths

• Right products

• Right people

• Right infrastructure

• Right environment

• Deliver quality product on time at competitive price

• Right quality procedures in practice

Right Products

*Patent non infringing *Patent non infringing

Product Strength Pellet Size

Category

Omeprazole Pellets 8.5%,10 % 14#1816#20

Anti-ulcerant

Lansoprazole Pellets 8.5% 14#1824#30

Anti-ulcerant

Itraconazole Pellets 22% 14#18 Anti-ulcerant

Esomeprazole Pellets 8.5% & 22.5%,22%

14#1816#20

Anti-ulcerant

Pantoprazole Pellets 15% ,22% 14#18 Anti-ulcerant

Tacrolimus Pellets 0.5%, 1% & 5% --- Immune-Suppressant

Clarithromycin Pellets 40% 20#30 Macrolide

Orlistat Pellets 50% -- Anti-obesity

Mesalazine Pellets 70% ---- Anti-ulcerant

Right Products

New Molecules in pipeline•Rapamycin (Sirolimus) Pellets 0.5%, 1%, 5%

•Mycophenolate Mofitil Pellets 50%

•Paclitaxel Pellets 25%, 50%

•Azithromycin Pellets 40%

We have a dedicated manufacturing facility for Immune-Suppressant Pellets

Total Plant Capacity at present : 12 MT Per Month

Advantage in using Enteric coated pellets Manufactured by MKPPL

• Ready to fill any size of capsules.

• No processing prior to capsule and dry syrup filling resulting.

in substantial cost and time saving.

• Easy to make dry syrup for children.

• No organic solvents used during coating or at any other stage

of manufacturing.• Better in-vitro and in-vivo absorption profile (matching with

innovators profile) for long term Pharmacological action

Right people Experienced work force and management team

Department M.Pharm B.Pharm M.Sc B.Sc/B.E B.Com M.Com/M.A

D.Pharm/D.E Other Total

Production 0 3 1 3 0 0 2 6 15

Quality Assurance

35 1 2 0 0 0 0 11

Quality Control 0 3 6 1 0 0 2 0 12

Warehouse 0 0 0 1 1 0 0 3 5

Engineering 0 0 0 0 0 0 1 7 8

Human Resources

0 0 0 0 0 2 0 0 2

Administration 0 0 0 0 0 1 1 2 5

Product Development Lab.

4 1 1 0 0 0 0 1 7

I.T. 0 0 0 1 0 0 0 0 1

Total 66

ORGANOGRAM

Director AdministrationMrs. Sitamahalakshmi

Challa

Director AdministrationMrs. Sitamahalakshmi

Challa

Technical DirectorDr. Vijay K. Shastri

Technical DirectorDr. Vijay K. Shastri

GM Manufacturing

Operations Mr. A. V. Kulkarni

GM Manufacturing

Operations Mr. A. V. Kulkarni

LogisticsLogistics

CMDMrs. Satya R. Vadlamani

CMDMrs. Satya R. Vadlamani

PurchasePurchase

FDA Liaison

Mr. K. V. Narale

FDA Liaison

Mr. K. V. Narale

Chief Finance OfficerMr. R. V. Ranjan

Chief Finance OfficerMr. R. V. Ranjan

Director Business Development & Technical Services

Dr. Pramod P. Karkhanis

Director Business Development & Technical Services

Dr. Pramod P. Karkhanis

Material Management & Procurement

Material Management & Procurement

Material Inventory Control

&

Product Inventory

Control

Material Inventory Control

&

Product Inventory

Control

DGM QC

Ms. Sushila Kumari

DGM QC

Ms. Sushila Kumari

Human Resources

Human Resources

Global Business Development, Global

Regulatory Compliance Ms.Tahera Dashti

Global Business Development, Global

Regulatory Compliance Ms.Tahera Dashti

Head Process Development Laboratory

Mr. T. Phanikumar

Head Process Development Laboratory

Mr. T. Phanikumar

Research &

Development

Research &

Development

Head Accounts Department

Ms. S. S. More

Head Accounts Department

Ms. S. S. More

GM Quality Assurance &

Regulatory AffairsMr. R. B. Patil

GM Quality Assurance &

Regulatory AffairsMr. R. B. Patil

DGM Quality Assurance & Regulatory compliance

Mr.S.B.Bhalekar

Mr. S. B. Bhalekar

DGM Quality Assurance & Regulatory compliance

Mr.S.B.Bhalekar

Mr. S. B. Bhalekar

Manager Engineering & Maintenance

Mr. D. M. Deshmukh

Manager Engineering & Maintenance

Mr. D. M. Deshmukh

Senior DGM ProductionSenior DGM Production

Material Handling, Store , Dispatch, Distribution.

Mr. T.K.Halande

Material Handling, Store , Dispatch, Distribution.

Mr. T.K.Halande

Asst.Mgr. QA&RA

Ms.Kavita Godase

Asst.Mgr. QA&RA

Ms.Kavita Godase

Management Team

• Mrs. Satya Vadlamani

Chairperson and Managing Director

• Dr. Vijay K Shastri

Director-Technical

• Dr.Pramod P. Karkhanis

Director-Business Development and Technical Services.

• Mrs. C. Sitamahalaxmi

Director – Administration

• Mr. Ranjan

CFO- Finance

Our Partners in Venture

• Rhenochem AG- Switzerland

Equity holders as well as marketing partners in Europe and

South America

• Elcon Hongkong Ltd.---Hongkong

Equity holders as well as marketing represntatives in China

Our clientele

European USA• Medichrom — Greece

• Farmoz — Portugal

• Slavia Pharm — Romania

• Welding Gmbh — Germany

• Rhenochem AG – Switzerland

• Karieb Kemi – UK

• Mylan Inc.

•Cutis Pharma Inc.

•Cogentus

Pharmaceuticals Inc.

•Geo Pharma Inc.

•Neuromoleculuar

Synthesis

Thank You!